CA
JAZZ icon

Crewe Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Crewe Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-20
Closed -$2.46K – 975
2023
Q4 		$2.46K Buy
+20
New +$2.5K ﹤0.01% 287
2023
Q3 		– Sell
-20
Closed -$2.48K – 749
2023
Q2 		$2.48K Sell
20
-44
-69% -$5.92K ﹤0.01% 518
2023
Q1 		$9.37K Hold
64
– – ﹤0.01% 561
2022
Q4 		$10.2K Hold
64
– – ﹤0.01% 548
2022
Q3 		$9K Hold
64
– – ﹤0.01% 697
2022
Q2 		$10K Buy
+64
New +$9.85K ﹤0.01% 594
2022
Q1 		– Sell
-60
Closed -$8K – 485
2021
Q4 		$8K Buy
+60
New +$7.88K ﹤0.01% 326

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return